|
Κυριακή 21 Μαρτίου 2021
Propranolol versus nadolol for treatment of pediatric subglottic hemangioma,,,,,Nadolol is a non-selective β-adrenergic antagonist that lacks intrinsic sympathomimetic activity and membrane-stabilizing properties. Nadolol is two to four times more potent than propranolol. The drug reduces IOP when administered topically in a concentration of 0.3–2%160 or orally in a dose of 20–40 mg. Nadolol - an overview | ScienceDirect Topicswww.sciencedirect.com › topics › neuroscience › nadolol
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου